Diamyd Medical’s phase 3 diabetes trial passes final safety review
Waystar Holding Corp (NASDAQ:WAY), a $6.58 billion market cap company currently trading at $36.82, saw its Chief Business Officer Eric L. (Ric) Sinclair III sell 9,701 shares of common stock on September 22, 2025. The sales were executed at a weighted average price of $37.6343, resulting in a total transaction value of $365,090. The prices for the shares sold ranged from $37.24 to $38.14. According to InvestingPro analysis, the company maintains a strong financial health score of "GREAT."
On the same day, Sinclair also exercised options to acquire 9,701 shares of Waystar Holding Corp. common stock at an exercise price of $4.14, for a total value of $40162. The company’s solid financial position is reflected in its healthy current ratio of 3.43, indicating strong liquidity management.
Following these transactions, Sinclair directly owns 474,826 shares of Waystar Holding Corp., which includes unvested Restricted Stock Units. These transactions were executed automatically under a Rule 10b5-1(c) plan adopted on February 19, 2025. For deeper insights into Waystar’s valuation and financial metrics, including 10 exclusive ProTips and comprehensive analysis, visit InvestingPro.
In other recent news, Waystar Holding Corp. has been added to the S&P SmallCap 600 Index, reflecting its growth and prominence in the market. The company has reported double-digit revenue growth and strong margins since its initial public offering. Waystar has also secured a favorable repricing of its term loan, reducing the interest rate and adding $250 million in incremental term loans. This financial maneuver is intended to support the acquisition of Iodine Software. Additionally, investment funds associated with EQT AB, Bain Capital, and the Canada Pension Plan Investment Board plan to sell 18 million shares in a secondary offering, though Waystar will not receive proceeds from this sale. Analyst firms have shown confidence in Waystar, with JMP and Baird both initiating coverage with Outperform ratings and setting price targets of $48.00 and $44.00, respectively. These developments highlight Waystar’s strategic financial decisions and the positive outlook from analysts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.